Actively Recruiting

Phase Not Applicable
Age: 18Years - 75Years
All Genders
NCT06275282

Regenerative Peripheral Nerve Interface for Control of Lower Limb Prostheses

Led by University of Michigan · Updated on 2025-08-26

3

Participants Needed

1

Research Sites

137 weeks

Total Duration

On this page

Sponsors

U

University of Michigan

Lead Sponsor

U

United States Department of Defense

Collaborating Sponsor

AI-Summary

What this Trial Is About

Individuals with an above-knee lower limb amputation are known to walk more slowly, expend more energy, have a greater risk of falling, and have reduced quality of life compared to individuals without amputation and those with below knee amputation. One of the driving factors behind these deficits is the lack of active function provided by above-knee prostheses with prosthetic knees and ankles. While many prosthetic devices have been developed for functional restoration after major lower extremity amputation, there remains no stable interface to facilitate reliable, long-term volitional control of an advanced robotic limb capable moving multiple joints. Moreover, there is no existing interface that provides useful sensory feedback that in turn enhances the functional capabilities of the prosthesis. To achieve both greater signal specificity and long-term signal stability, we have developed a biologic interface known as the Regenerative Peripheral Nerve Interface (RPNI). An RPNI consists of a peripheral nerve that is implanted into a free muscle graft that would otherwise go unused in the residual limb. As the nerve grows, it reinnervates the free muscle graft which undergoes a predictable sequence of revascularization and regeneration. The main questions it aims to answer are: 1. Can the amplitude, movement specificity and stability of sciatic nerve RPNI electromyography (EMG) signals be detected up to one year post RPNI surgery? 2. Do RPNIs contain information to enable control of a physical motorized prosthetic leg with multiple degrees of freedom? 3. Does stimulation of sciatic nerve RPNIs provides meaningful sensory feedback? Consenting participants with unilateral transfemoral amputation (TFA) will: 1. Undergo RPNI surgery and electrode implantation in the residual limb. 2. Attend regular follow-up visits following surgery to assess the health and signal strength of the RPNIs and their ability to use a prescribed prosthesis between 3- and 12-months following implantation. 3. Undergo explantation of electrodes following the conclusion of data collection.

CONDITIONS

Official Title

Regenerative Peripheral Nerve Interface for Control of Lower Limb Prostheses

Who Can Participate

Age: 18Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Unilateral leg amputation above the knee at least 6 months before enrollment
  • Low surgical risk classified as American Society of Anesthesiologists Class I or II
  • Residual limb with enough soft tissue quality to support RPNI surgery (no severe crushing or scarring injuries)
  • Amputee Mobility Predictor with prosthesis (AMPPRO) score of 37 or higher
  • Ability to use a motorized prosthetic leg without shoe lifts or extenders on the other leg
Not Eligible

You will not qualify if you...

  • Severe pain syndromes such as complex regional pain syndrome or severe phantom pain
  • Untreated mental health disorders without approval from a mental health professional
  • Medical conditions posing high surgical risk like recent heart attack, stroke, blood clots, uncontrolled diabetes, or end-stage kidney disease
  • Tobacco use within one month before enrollment or planned use during the study
  • Pregnancy
  • Presence of other implanted electronic devices like pacemakers or neurostimulators
  • Severe peripheral vascular disease, venous hypertension, or severe lymphedema in the affected limb
  • Uncontrolled autoimmune conditions
  • Significant injury to the opposite limb
  • Severe uncorrected vision problems
  • Impaired mental capacity affecting communication or requiring a legal representative

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University of Michigan

Ann Arbor, Michigan, United States, 48109

Actively Recruiting

Loading map...

Research Team

D

Deanna Gates, PhD

CONTACT

J

Jennifer B Hamill, MPH

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

BASIC_SCIENCE

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Regenerative Peripheral Nerve Interface for Control of Lower Limb Prostheses | DecenTrialz